Sequencing Start-up Genome Corp. Lands $250K in Seed Funding from Slater Fund | GenomeWeb
NEW YORK (GenomeWeb News) - Genome Corp., a sequencing start-up based in Providence, RI, has received a $250,000 seed capital investment from the Slater Technology Fund, the companies said today.
 
Genome Corp. was founded earlier this year to develop and commercialize a sequencing method it calls “massively parallel Sanger sequencing,” a single-molecule approach that is expected to "greatly accelerate the speed and significantly reduce the cost of genome sequencing," according to the firm.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.